Genetic mutations in Col1a1 or Col1a2 genes (or other genes affecting Col1 biosynthesis) in humans lead to multiple subtypes of Osteogenesis Imperfecta (OI) syndrome, a bone disease referred to as the ‘brittle bone disease’3–5. The gene discussed is COL1A1; the disease is osteogenesis imperfecta.